AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure

NCT01966887 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure Congestive
Ischemic Cardiomyopathy
Non-ischemic Cardiomyopathy

Interventions

GENETIC: MYDICAR-single intracoronary infusion
GENETIC: Placebo; single intracoronary infusion

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]